Clinical Trials Logo

2019 Novel Coronavirus Pneumonia clinical trials

View clinical trials related to 2019 Novel Coronavirus Pneumonia.

Filter by:
  • None
  • Page 1

NCT ID: NCT04275388 Not yet recruiting - Clinical trials for 2019 Novel Coronavirus Pneumonia

Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia

Start date: May 15, 2020
Study type: Observational

the investigators conduct a randomized, open-label trial to evaluate and compare the safety and efficacy of Xiyanping injection in patients with 2019-nCoV pneumonia.

NCT ID: NCT04273646 Not yet recruiting - COVID-19 Clinical Trials

Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19

Start date: April 20, 2020
Phase: N/A
Study type: Interventional

The novel coronavirus pneumonia is a kind of new emerging respiratory infectious disease, characterized by fever, dry cough, and chest tightness, and caused by the infection of the 2019 novel coronavirus (2019-nCoV). In severe cases, there will be rapid respiratory system failure. The novel coronavirus pneumonia is extremely contagious and the disease progresses rapidly. It has become a urgent and serious public health event that threatens human life and health globally. Among them, severe pneumonia caused by novel coronavirus is characterized by extensive acute inflammation of the lungs and the patient is critically ill. At present, there is no effective treatment in clinical practice.Most of them should receive supportive care to help relieve symptoms. For severe cases, treatment should include care to support vital organ functions. This clinical trial is to inspect the safety and efficiency of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) therapy for severe pneumonia patients infected with 2019-nCoV.